Successful launches and sustained revenue growth from new products are the lifeblood of the pharmaceutical industry. While the forecasted spending on new brands is expected to add $196 billion over the next five yearsi, achieving success has become elusive. IQVIA’s recent Launch Excellence studies demonstrate just how difficult it is to succeed in the current pharmaceutical landscapeii.